PAveMenT: Palbociclib and Avelumab in Metastatic AR+ Triple Negative Breast Cancer
PAveMenT: Palbociclib and Avelumab in Metastatic AR+ Triple Negative Breast Cancer
Active, not recruiting · NCT04360941 · Registry updated 2026-08-21Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| PAveMenT: Palbociclib and Avelumab in Metastatic AR+ Triple Negative Breast Cancer | Neoplasms by Site, Skin and Connective Tissue Diseases, breast disorder, breast neoplasm, estrogen-receptor positive breast cancer, neoplasm, skin disorder, triple-negative breast carcinoma | Active, not recruiting | Phase 1 | 2026-08-21 | NCT04360941 |
3 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Breast Cancer Now | 2 |
| Pfizer | 431 |
| Royal Marsden NHS Foundation Trust | 89 |
9 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| Addenbrooke's Hospital Cambridge University Hospitals NHS Foundation Trust | Cambridge | United Kingdom | 1 |
| Barts Cancer Institute | London | United Kingdom | 1 |
| Beatson West of Scotland Cancer Centre | Glasgow | United Kingdom | 39 |
| Hope Clinical Trials Cancer Centre | Leicester | United Kingdom | 1 |
| Nottingham University Hospital | Nottingham | United Kingdom | 6 |
| Royal Marsden NHS Foundation Trust | London | United Kingdom | 11 |
| The Christie NHS Foundation Trust | Manchester | United Kingdom | 6 |
| University College London Hospitals NHS Foundation Trust | London | United Kingdom | 8 |
| Weston Park Hospital | Sheffield | United Kingdom | 17 |